Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: A cross-sectional study

Emergency Medicine Journal

Volumn 31, Issue 1, 2014, Pages 24-29

  Ahern, Fiona ^a   Sahm, Laura J ^b,c   Lynch, Deirdre ^a   McCarthy, Suzanne ^a,b  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; BORTEZOMIB; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CLOZAPINE; DIURETIC AGENT; ESCITALOPRAM; FLUOXETINE; INSULIN; LITHIUM; METFORMIN; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NICORANDIL; RAMIPRIL; ROSUVASTATIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THALIDOMIDE; WARFARIN;

ACUTE KIDNEY FAILURE; ADVERSE DRUG REACTION; AGED; ARTICLE; ATAXIA; BRADYCARDIA; COLLAPSE; CONFUSION; CONSTIPATION; CROSS-SECTIONAL STUDY; DEHYDRATION; DELIRIUM; DIZZINESS; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; HYPONATREMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NEUROPATHY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SEIZURE; SKIN ULCER; TONIC CLONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

RESEARCH, EPIDEMIOLOGY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; IRELAND; MALE; MIDDLE AGED;

EID: 84891888347     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2012-201945     Document Type: Article

References (25)

1. Stuart MC, Kouimtzi M, Hill SR. WHO model formulary. Geneva: World Health Organisation, 2008.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
3. Vervloet D, Durham S. Adverse reactions to drugs. BMJ 1998;316:1511-14.
4. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.
5. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
6. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007;7:9.
7. Leendertse AJ, Visser D, Egberts AC, et al. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf 2010;33:233-44.
8. Rogers S, Wilson D, Wan S, et al. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging 2009;26:951-61.
9. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007;34:494-8.
10. Health Service Executive. Profile of Cork University Hospital. 2010 (accessed: 1st Aug 2010).
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
12. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009;9:5.
13. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-9.
14. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990;228:83-90.
15. Hakkarainen KM, Hedna K, Petzold M, et al. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis. PLoS One 2012;7:e33236.
16. McGinn T, Wyer PC, Newman TB, et al. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004;171:1369-73.
17. Anatomical Therapeutical Chemical (ATC) classification index. http://www.whocc.no/atc-ddd-index/
18. Wiffen P, Gill M, Edwards J, et al. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra 2002;June:1-15.
19. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010;170:1142-8.
20. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-25.
21. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47.
22. Arimone Y, Miremont-Salame G, Haramburu F, et al. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 2007;64:482-8.
23. Arimone Y, Begaud B, Miremont-Salame G, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005;61:169-73.
24. Garcia-Cortes M, Lucena MI, Pachkoria K, et al. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008;27:780-9.
25. British Medical Association. Royal pharmaceutical society of Great Britain: British National Formulary. 59th edn. London: Pharmaceutical Press, 2010.